These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 17596573

  • 1. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement.
    Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK.
    J Natl Cancer Inst; 2007 Jul 04; 99(13):1044-9. PubMed ID: 17596573
    [Abstract] [Full Text] [Related]

  • 2. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A, Ward E, Thun MJ.
    Breast Cancer Res; 2007 Jul 04; 9(3):R28. PubMed ID: 17477859
    [Abstract] [Full Text] [Related]

  • 3. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.
    J Natl Cancer Inst; 2008 Apr 02; 100(7):462-74. PubMed ID: 18364506
    [Abstract] [Full Text] [Related]

  • 4. Breast carcinoma survival in Europe and the United States.
    Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Crosignani P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Møller H, Paci E, Raverdy N, Tretarre B, Williams EM, European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group.
    Cancer; 2004 Feb 15; 100(4):715-22. PubMed ID: 14770426
    [Abstract] [Full Text] [Related]

  • 5. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS, van der Heiden-van der Loo M, Hennipman A.
    Eur J Surg Oncol; 2009 Jan 15; 35(1):25-31. PubMed ID: 18640809
    [Abstract] [Full Text] [Related]

  • 6. A decision tool for predicting sentinel node accuracy from breast tumor size and grade.
    Coombs N, Chen W, Taylor R, Boyages J.
    Breast J; 2007 Jan 15; 13(6):593-8. PubMed ID: 17983402
    [Abstract] [Full Text] [Related]

  • 7. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.
    J Clin Oncol; 2007 Oct 01; 25(28):4423-30. PubMed ID: 17906205
    [Abstract] [Full Text] [Related]

  • 8. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
    Chen AY, Jemal A, Ward EM.
    Cancer; 2009 Aug 15; 115(16):3801-7. PubMed ID: 19598221
    [Abstract] [Full Text] [Related]

  • 9. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, Rosali dos Santos G, Viale G, Luini A.
    Breast Cancer Res Treat; 2008 Dec 15; 112(3):513-21. PubMed ID: 18240020
    [Abstract] [Full Text] [Related]

  • 10. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 Dec 15; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 11. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI, Daling JR, Malone KE.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 15; 14(4):1008-11. PubMed ID: 15824180
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL, Hoehne FM, Giuliano AE.
    Ann Surg Oncol; 2007 Dec 15; 14(12):3378-84. PubMed ID: 17899293
    [Abstract] [Full Text] [Related]

  • 13. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D.
    Bull Cancer; 2008 Dec 15; 95(7):763-72. PubMed ID: 18755653
    [Abstract] [Full Text] [Related]

  • 14. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Chu KC, Chang S, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul 15; 13(7):1128-35. PubMed ID: 15247123
    [Abstract] [Full Text] [Related]

  • 15. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, Suzuki T, Nakahara T, Kitamura N, Kubo A, Mukai M, Ikeda T, Kitajima M.
    Breast J; 2008 Jul 15; 14(6):551-5. PubMed ID: 19000054
    [Abstract] [Full Text] [Related]

  • 16. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.
    Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ.
    Ann Epidemiol; 2005 Nov 15; 15(10):773-80. PubMed ID: 16257362
    [Abstract] [Full Text] [Related]

  • 17. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
    Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, Hoon DS.
    Clin Cancer Res; 2007 Jul 15; 13(14):4105-10. PubMed ID: 17634536
    [Abstract] [Full Text] [Related]

  • 18. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):121-31. PubMed ID: 19124489
    [Abstract] [Full Text] [Related]

  • 19. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.
    Eur J Surg Oncol; 2009 Aug 15; 35(8):805-13. PubMed ID: 19046846
    [Abstract] [Full Text] [Related]

  • 20. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA.
    Cancer; 2008 Apr 01; 112(7):1437-44. PubMed ID: 18286526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.